Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67